Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

An anti-afp nanobody 1c5 and its application

A nanobody and expression carrier technology, applied in the field of immunology, can solve the problems of poor tumor permeability and low targeting effect, and achieve excellent detection performance and broad-spectrum adaptability

Active Publication Date: 2022-04-01
深圳市国创纳米抗体技术有限公司
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] The purpose of the present invention is to provide an anti-AFP nanobody that can give full play to the superior performance of the nanobody, which not only has excellent specific antigen binding ability, but also overcomes the inherent defects of traditional antibodies such as poor permeability to solid tumors and low targeting effect. , and further provide its application in the preparation of tumors, especially liver cancer therapeutic drugs and diagnostic preparations

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • An anti-afp nanobody 1c5 and its application
  • An anti-afp nanobody 1c5 and its application
  • An anti-afp nanobody 1c5 and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Example 1. Construction and screening of Nanobody phage display library

[0033] 1.1 Immunity of alpacas

[0034] A healthy adult alpaca was selected, and the recombinant AFP antigen (Aibisin Biological, product number Abt-P-208, GenbankID: 174, https: / / www.ncbi.nlm.nih.gov / gene / 174) and Freund's The adjuvant was mixed at a ratio of 1:1, and the alpaca was immunized with 6-7 μg / kg subcutaneously at multiple points on the back, and immunized four times with an interval of 2 weeks. Afterwards, the peripheral blood of the alpaca was collected for the construction of a phage display library.

[0035] 1.2 Isolation of camel-derived lymphocytes

[0036] Lymphocytes were separated from the collected alpaca peripheral blood using the Camel Peripheral Blood Lymphocyte Separation Solution Kit (Tianjin Haoyang Company, Cat. No. LTS1076). 7 Add 1ml RNA isolation reagent to each living cell, take 1ml for RNA extraction, and store the rest at -80°C.

[0037] 1.3 Total RNA extract...

Embodiment 2

[0065] Example 2. Preparation of Nanobody 1C5

[0066] 2.1 Amplification of original nanobody strain TG1 and transformation of nanobody recombinant plasmid into Escherichia coli BL21(DE3)

[0067] Inoculate 5 ml of fresh LB-A medium at a ratio of 1:1000 to inoculate the original strain TG1 Glycerobacterium containing Nanobody nucleic acid, and culture overnight at 37°C and 200 rpm. The next day, plasmids were extracted using the Plasmid mini kit (OMEGA) according to the instructions. After verification, transform 1 μl of the above plasmid into 100 μl competent cells, mix gently, place on ice for 30 minutes, heat shock in a 42°C water bath for 90 seconds, and cool in an ice bath for 3 minutes. Add 600 μl LB medium to the centrifuge tube, shake and incubate at 37°C for 60 minutes. Take 100 μl of the supernatant, spread it on the LB-A plate with a triangular spreader, and culture it upside down at 37°C overnight.

[0068] 2.2 Induced expression of nanobodies

[0069] The abov...

Embodiment 3

[0072] Example 3. Determination of the affinity and activity of nanobodies and antigens

[0073] 3.1 Chip antigen coupling

[0074] The antigen was formulated into a 20 μg / ml working solution with different pH sodium acetate buffers (pH 5.5, pH 5.0, pH 4.5, pH 4.0), and a 50 mM NaOH regeneration solution was prepared at the same time, and the Biacore T100 protein interaction analysis system instrument was used to The template method is used to analyze the electrostatic binding between the antigen and the surface of the chip (GE company) under different pH conditions, and the signal increase amount reaches 5 times RL as the standard, select the most suitable neutral pH system and adjust it as needed The antigen concentration was used as the condition during coupling. The chip was coupled according to the template method that comes with the instrument: select the blank coupling mode for channel 1, select the Target coupling mode for channel 2, and set the target to the designed...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an anti-AFP nanobody, the nanobody has three unique complementarity determining regions CDR1, CDR2, CDR3, the invention also provides an expression vector containing the coding sequence of the nanobody variable region, containing the The host cell of the expression vector, and the application of the nanobody in the preparation of tumor therapeutic drugs and tumor diagnostic reagents. The nanobody provided by the present invention has specific recognition and binding ability to AFP, the affinity of the nanobody can reach 2.716E-09, has a unique antigenic determinant recognition site, has a significant ADCC effect on cancer cells, and can be used in AFP Serum detection, especially in the double antibody sandwich method, has achieved excellent detection results.

Description

technical field [0001] The invention discloses a nanobody and belongs to the field of immunology. Background technique [0002] Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world, and the incidence in my country accounts for about 55% of the world. It ranks second in the mortality rate of all tumors in my country, second only to lung cancer. Alpha-fetoprotein (alpha-fetoprotein, AFP) was first discovered by Bergstrandh and Czar in human fetal serum. It is currently the most widely used HCC tumor marker and is widely used in the examination of related diseases. AFP is a glycoprotein belonging to the albumin family with a molecular weight of 69kDa. Generally, AFP is mainly secreted by embryonic liver cells. Because of the difference in its sugar chain structure, there are differences in AFP molecules. At present, it is believed that there are at least three heterogeneous forms (AFP2L1, AFP2L2, AFP2L3). AFP exists in human serum and is derived from th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/30C07K19/00C12N15/13C12N15/70C12N1/21A61K39/395A61P35/00G01N33/574C12R1/19
CPCC07K16/303C12N9/16C12N15/70A61P35/00G01N33/57476G01N33/57438C12Y301/03001C07K2317/565C07K2317/569C07K2317/22C07K2317/92C07K2319/00G01N2333/471A61K2039/505
Inventor 宋海鹏刘原源于建立蒋立仲王准曹慧古一李飞张霞
Owner 深圳市国创纳米抗体技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com